Ingredients and solutions for the food industry
Microorganisms and active ingredients for human health
Lactic acid bacteria for the agri-veterinary sector

Sacco System grows in Latin America: BioInsumos in Uruguay and Sacco Brasil acquired.

22/12/2025

The Group is accelerating its South American growth strategy through a twofold transaction: the acquisition of a Uruguayan company and the full absorption of its Brazilian subsidiary. The Group is targeting €190 million in revenue in 2025 (+10%) versus 2024.

Sacco System is stepping up its international expansion and is setting its sights firmly on South America. The biotech Group headquartered in Cadorago (Como, Italy), specialized in the production of microbial cultures and probiotics for the food, nutraceutical, pharmaceutical, and agro-veterinary sectors, announces the acquisition of the Uruguayan company BioInsumos and the full integration of Sacco Brasil, its commercial division already operating in the country. These will henceforth be known as Sacco System Uruguay and Sacco System Brasil, respectively.

This dual acquisition forms part of the Group’s international growth strategy. Sacco System operates in more than 110 countries and expects pro-forma consolidated revenue of €190 million in 2025, up 10% year-on-year. The transaction strengthens the brand’s presence in existing markets and opens up new development opportunities, further consolidating Sacco System’s position among the leading international players in the sector.

A targeted expansion strategy

Latin America is a strategic region for companies in the biotechnology and food industries. Growing demand for innovative solutions, together with the expansion of the probiotics and supplements market, makes the region particularly attractive for international operators.

The Latin American dairy sector—where Sacco System is consolidating its presence—is worth between USD 45 and 55 billion and is forecast to grow at 4.5% per year through 2034. This growth is driven by rising domestic consumption, the expansion of agribusiness, and increasing demand for high value-added ingredients.

The acquisition of BioInsumos (now Sacco System Uruguay) enables Sacco System to deepen local expertise, leverage established distribution networks, and strengthen its understanding of the dynamics of the Uruguayan market and neighboring countries. Although relatively small in size, Uruguay has traditionally served as an important gateway to Mercosur, the free-trade area that includes Brazil, Argentina, Paraguay, and other South American countries.

At the same time, the incorporation of Sacco System Brasil into the Group underscores the growing importance of the Brazilian market in Sacco System’s strategy. Brazil—with more than 200 million inhabitants and one of the world’s most developed agri-food industries—offers significant growth opportunities in both the dairy sector and in fermented products and nutraceuticals.

Strengthening the local presence means not only increasing production and distribution capacity, but also bringing research and development closer to the specific needs of the South American market, which is shaped by climatic, regulatory, and consumer characteristics that differ from Europe.

“This investment in South America confirms the Group’s determination to pursue its global vision, in a context that is particularly favorable to biotechnological innovation and the scaling up of operations,” says Carlo Appennini, Executive Director Food at Sacco System. “The experience developed by BioInsumos and Sacco Brasil is, in this sense, a crucial added value, allowing us to operate closer to local markets, improve our responsiveness, and tailor solutions more effectively.”

Growth in numbers

Sacco System has an industrial and commercial structure with a strong international footprint, built on an integrated network of distributors, agents, and technologists, and on a production perimeter comprising eight plants and four laboratories across Europe, Asia, Australia, Latin America, and the United States. In Italy, the Group operates through the sites of Cadorago—home to Sacco and Caglificio Clerici—Zelo Buon Persico, headquarters of the Centro Sperimentale del Latte, and Camerino, where Synbiotec is based. Internationally, the Group is present in France, Sweden, the United States, Singapore, Japan, and Australia, confirming a direct presence in its key reference markets.

The revenue mix reflects a well-established strategy of geographic diversification: 65% of revenue comes from exports, while the Italian market accounts for the remaining 35%. Latin America stands out for its dynamism, with a particular focus on Uruguay, Brazil, and Argentina, while Mexico is the main contributor in Central America.

The global dairy market continues to expand, with estimates placing it at USD 648.8 billion in 2025 and an average annual growth rate of 4.59% through 2033. Europe remains a key market: while it represents about a quarter of volumes, it accounts for 30–35% of value thanks to premium cheeses and ingredients, with more moderate growth of 1.4% per year. North America maintains a solid position, with expected values of USD 144.6 billion in 2025 and a projected growth rate of 3.84%. Asia-Pacific, meanwhile, is emerging as the most dynamic region, with forecast annual growth of 7.10%, confirming it as a frontier of opportunity.

In this context, market distribution and global trends offer Sacco System—thanks to its broad reach—strong growth opportunities in the highest-potential regions, in line with a geographic balancing strategy that helps mitigate country risk and capture areas with the highest growth rates.

Latest news

04 September 2026
CSL USA expands its probiotic manufacturing capabilities with integrated encapsulation and packaging

CSL USA Inc., a Sacco System company, is expanding its manufacturing facility in Franksville, Wisconsin, with new fully automated encapsulation and bottle packaging capabilities. The investment further strengthens CSL USA’s

19 March 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 January 2026
SYNBIO: Sacco System's probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

11 December 2025
Sacco System Presents PerforMilk®: Unlocking Milk’s Full Potential by Preserving Protein Quality 

Milk is the most precious resource in dairy production. High-quality dairy products start with high-quality milk—and in today’s rapidly evolving dairy landscape, protecting that quality has never been more critical. 

20 November 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 February 2025
Lacticaseibacillus rhamnosus CA15 Achieves GRAS Status: A Milestone for Women's Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 January 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 November 2024
News
Our 2023 sustainability report is online!

We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved and the challenges ahead…

16 April 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland…

26 March 2024
News
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici…

18 March 2024
News
List Biotherapeutics and Sacco System Announce Lead Share Agreement

List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement…

26 February 2024
News
CSL FRANCE becomes SACCO SYSTEM FRANCE

Sacco System is the international biotechnological company dedicated to the food, nutraceutical, and pharmaceutical industries…